作者: Michael C. Heinrich , Francis Y. Lee
DOI:
关键词:
摘要: The invention described herein relates to methods of identifying and treating individuals with protein tyrosine kinase associated disorders that have, or may, become resistant treatment a inhibitor such as imatinib due gain-of- function mutation in KIT kinase.